
BIOXCEL THERAPEUT
Aktie · US09075P1057 · BTAI · A2JF20 (LSSI)
1,75 EUR
10.06.2025 23:45
Aktuelle Kurse von BIOXCEL THERAPEUT
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
---|---|---|---|---|---|
![]() NASDAQ |
BTAI
|
USD
|
10.06.2025 23:45
|
2,00 USD
| 1,96 USD
+2,04 %
|
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 28,44 % | 30,13 % | -39,38 % | -73,87 % | -91,84 % | -99,76 % |
Firmenprofil zu BIOXCEL THERAPEUT Aktie
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.
Unternehmensdaten
Name BIOXCEL THERAPEUT
Firma BioXcel Therapeutics, Inc.
Symbol BTAI
Heimatbörse
Lang & Schwarz

WKN A2JF20
ISIN US09075P1057
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Vimal D. Mehta Ph.D.
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,0 T
Adresse 555 Long Wharf Drive, 06511 New Haven
IPO Datum 2018-03-08
Aktien-Splits
Datum | Split |
---|---|
10.02.2025 | 1:16 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | BX2.F |
NASDAQ | BTAI |
Weitere Aktien
Investoren die BIOXCEL THERAPEUT die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.